Immuneering Corp Quarterly Operating Margin in % from Q4 2021 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Immuneering Corp quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2023.
  • Immuneering Corp Operating Margin for the quarter ending September 30, 2023 was -12.3M %, a 127560% decline year-over-year.
  • Immuneering Corp annual Operating Margin for 2022 was -16.3K %, a 902% decline from 2021.
  • Immuneering Corp annual Operating Margin for 2021 was -1.63K %, a 120% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -12.3M -12.3M -127560% Jul 1, 2023 Sep 30, 2023
Q2 2023 -143K -138K -2961% Apr 1, 2023 Jun 30, 2023
Q1 2023 -40.1K -37.5K -1399% Jan 1, 2023 Mar 31, 2023
Q4 2022 -16.3K -14.7K -902% Oct 1, 2022 Dec 31, 2022
Q3 2022 -9.66K Jul 1, 2022 Sep 30, 2022
Q2 2022 -4.66K Apr 1, 2022 Jun 30, 2022
Q1 2022 -2.68K Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.63K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.